Focus Partners Wealth
BIIB icon

Focus Partners Wealth’s Biogen BIIB Stock Holding History

Focus Partners Wealth’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.33M Buy
24,689
+3,707
+18% +$709K 0.01% 935
2026
Q1 		$3.85M Buy
20,982
+6,401
+44% +$1.18M ﹤0.01% 1033
2025
Q4 		$2.57M Buy
14,581
+4,664
+47% +$762K ﹤0.01% 1216
2025
Q3 		$1.41M Buy
9,917
+3,209
+48% +$434K ﹤0.01% 1151
2025
Q2 		$843K Sell
6,708
-3,465
-34% -$432K ﹤0.01% 1217
2025
Q1 		$1.39M Buy
10,173
+6,395
+169% +$914K ﹤0.01% 955
2024
Q4 		$578K Buy
3,778
+1,061
+39% +$179K ﹤0.01% 1265
2024
Q3 		$422K Buy
2,717
+1,485
+121% +$311K ﹤0.01% 1203
2024
Q2 		$286K Buy
+1,232
New +$268K ﹤0.01% 1079

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Focus Partners Wealth's BIIB Position: Q2 2026 in Review

Focus Partners Wealth increased its Biogen (BIIB) stake by 18% in Q2 2026, buying an estimated $709K and bringing the position to 24,689 shares worth $5.33M. The position accounts for 0.01% of the portfolio, ranked #935.

Focus Partners Wealth first reported a position in BIIB in Q2 2024 and has held it in 9 quarters since. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Focus Partners Wealth held 24,689 shares of Biogen worth $5.33M as of Q2 2026.
  • Focus Partners Wealth bought 3,707 Biogen shares in Q2 2026, an estimated $709K.
  • Biogen made up 0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #935 holding.
  • Focus Partners Wealth first reported a position in Biogen in Q2 2024 and has held it in 9 quarters since.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.